Cargando…

Green tea and the risk of prostate cancer: A systematic review and meta-analysis

Prostate cancer (PCa) now remains the 2nd most frequently diagnosed cancer. In recent years, chemoprevention for PCa becomes a possible concept. Especially, many phytochemicals rich foods are suggested to lower the risk of cancer. Among these foods, green tea is considered as effective prevention fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yuming, Zhi, Fan, Chen, Ping, Zhao, Keke, Xiang, Han, Mao, Qi, Wang, Xinghuan, Zhang, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380255/
https://www.ncbi.nlm.nih.gov/pubmed/28353571
http://dx.doi.org/10.1097/MD.0000000000006426
_version_ 1782519746512551936
author Guo, Yuming
Zhi, Fan
Chen, Ping
Zhao, Keke
Xiang, Han
Mao, Qi
Wang, Xinghuan
Zhang, Xinhua
author_facet Guo, Yuming
Zhi, Fan
Chen, Ping
Zhao, Keke
Xiang, Han
Mao, Qi
Wang, Xinghuan
Zhang, Xinhua
author_sort Guo, Yuming
collection PubMed
description Prostate cancer (PCa) now remains the 2nd most frequently diagnosed cancer. In recent years, chemoprevention for PCa becomes a possible concept. Especially, many phytochemicals rich foods are suggested to lower the risk of cancer. Among these foods, green tea is considered as effective prevention for various cancers. However, clinical trials and previous meta-analyses on the relationship between green tea consumption and the risk of PCa have produced inconsistent outcomes. This study aims to determine the dose–response association of green tea intake with PCa risk and the preventive effect of green tea catechins on PCa risk. Seven observational studies and 3 randomized controlled trials were retrieved from Cochrane Library, PubMed, Sciencedirect Online, and hand searching. The STATA (version 12.0) was applied to analyze the data. The relative risks (RRs) and 95% confidence intervals were pooled by fixed or random effect modeling. Dose–response relations were evaluated with categories of green tea intake. Although there was no statistical significance in the comparison of the highest versus lowest category, there was a trend of reduced incidence of PCa with each 1 cup/day increase of green tea (P = 0.08). Our dose–response meta-analysis further demonstrated that higher green tea consumption was linearly associated with a reduced risk of PCa with more than 7 cups/day. In addition, green tea catechins were effective for preventing PCa with an RR of 0.38 (P = 0.02). In conclusion, our dose–response meta-analysis evaluated the association of green tea intake with PCa risk systematically and quantitatively. And this is the first meta-analysis of green tea catechins consumption and PCa incidence. Our novel data demonstrated that higher green tea consumption was linearly reduced PCa risk with more than 7 cups/day and green tea catechins were effective for preventing PCa. However, further studies are required to substantiate these conclusions.
format Online
Article
Text
id pubmed-5380255
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-53802552017-04-12 Green tea and the risk of prostate cancer: A systematic review and meta-analysis Guo, Yuming Zhi, Fan Chen, Ping Zhao, Keke Xiang, Han Mao, Qi Wang, Xinghuan Zhang, Xinhua Medicine (Baltimore) 7300 Prostate cancer (PCa) now remains the 2nd most frequently diagnosed cancer. In recent years, chemoprevention for PCa becomes a possible concept. Especially, many phytochemicals rich foods are suggested to lower the risk of cancer. Among these foods, green tea is considered as effective prevention for various cancers. However, clinical trials and previous meta-analyses on the relationship between green tea consumption and the risk of PCa have produced inconsistent outcomes. This study aims to determine the dose–response association of green tea intake with PCa risk and the preventive effect of green tea catechins on PCa risk. Seven observational studies and 3 randomized controlled trials were retrieved from Cochrane Library, PubMed, Sciencedirect Online, and hand searching. The STATA (version 12.0) was applied to analyze the data. The relative risks (RRs) and 95% confidence intervals were pooled by fixed or random effect modeling. Dose–response relations were evaluated with categories of green tea intake. Although there was no statistical significance in the comparison of the highest versus lowest category, there was a trend of reduced incidence of PCa with each 1 cup/day increase of green tea (P = 0.08). Our dose–response meta-analysis further demonstrated that higher green tea consumption was linearly associated with a reduced risk of PCa with more than 7 cups/day. In addition, green tea catechins were effective for preventing PCa with an RR of 0.38 (P = 0.02). In conclusion, our dose–response meta-analysis evaluated the association of green tea intake with PCa risk systematically and quantitatively. And this is the first meta-analysis of green tea catechins consumption and PCa incidence. Our novel data demonstrated that higher green tea consumption was linearly reduced PCa risk with more than 7 cups/day and green tea catechins were effective for preventing PCa. However, further studies are required to substantiate these conclusions. Wolters Kluwer Health 2017-03-31 /pmc/articles/PMC5380255/ /pubmed/28353571 http://dx.doi.org/10.1097/MD.0000000000006426 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 7300
Guo, Yuming
Zhi, Fan
Chen, Ping
Zhao, Keke
Xiang, Han
Mao, Qi
Wang, Xinghuan
Zhang, Xinhua
Green tea and the risk of prostate cancer: A systematic review and meta-analysis
title Green tea and the risk of prostate cancer: A systematic review and meta-analysis
title_full Green tea and the risk of prostate cancer: A systematic review and meta-analysis
title_fullStr Green tea and the risk of prostate cancer: A systematic review and meta-analysis
title_full_unstemmed Green tea and the risk of prostate cancer: A systematic review and meta-analysis
title_short Green tea and the risk of prostate cancer: A systematic review and meta-analysis
title_sort green tea and the risk of prostate cancer: a systematic review and meta-analysis
topic 7300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380255/
https://www.ncbi.nlm.nih.gov/pubmed/28353571
http://dx.doi.org/10.1097/MD.0000000000006426
work_keys_str_mv AT guoyuming greenteaandtheriskofprostatecancerasystematicreviewandmetaanalysis
AT zhifan greenteaandtheriskofprostatecancerasystematicreviewandmetaanalysis
AT chenping greenteaandtheriskofprostatecancerasystematicreviewandmetaanalysis
AT zhaokeke greenteaandtheriskofprostatecancerasystematicreviewandmetaanalysis
AT xianghan greenteaandtheriskofprostatecancerasystematicreviewandmetaanalysis
AT maoqi greenteaandtheriskofprostatecancerasystematicreviewandmetaanalysis
AT wangxinghuan greenteaandtheriskofprostatecancerasystematicreviewandmetaanalysis
AT zhangxinhua greenteaandtheriskofprostatecancerasystematicreviewandmetaanalysis